Two novel gene mutations in type I antithrombin deficiency

Kenji Niiya, Toru Kiguchi, Hiromichi Dansako, Kingo Fujimura, Takahiro Fujimoto, Kenji Iijima, Mitsune Tanimoto, Mine Harada

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We studied the molecular basis of type I antithrombin (AT) deficiency in 2 Japanese families, in which affected persons had histories of recurrent venous thrombosis and low (about 50% of normal) levels of AT protein according to measurements by both functional and antigen assays. Southern blotting of DNA isolated from peripheral leukocytes revealed no abnormalities in all the cases examined. Direct sequencing of the polymerase chain reaction (PCR) products from case 1 suggested a novel heterozygous nonsense mutation in exon 4 (GAG→TAG at nucleotide position 7627, leading to Glu306 stop). The sequencing of the subclones of the patient's exon 4 products confirmed the nonsense mutation. No other sequence abnormalities were detected in the rest of the PCR products. The same mutation was detected in this patient's brother, who had a history of recurrent venous thrombosis and a reduced level of AT activity. In case 2, the direct sequencing of PCR products suggested a novel heterozygous 9-bp deletion in exon 3a(-CACTTC at nucleotide position 5354-5362, leading to the deletion of 3 amino acids, His120, Phe121, and Phe122). The 9-bp deletion mutation in the region of a unique quasi palindrome was confirmed by sequencing several of the subclones of the patient's exon 3a from the PCR products. No other mutations were found by direct sequencing of the rest of the coding regions. The 2 mutations found in this study are novel. The use of PCR and the sequencing of the PCR product subclones has simplified and confirmed the detection and characterization of the various AT muta-tions.

Original languageEnglish
Pages (from-to)469-472
Number of pages4
JournalInternational Journal of Hematology
Volume74
Issue number4
Publication statusPublished - 2001

Fingerprint

Fibrin
Polymerase Chain Reaction
Mutation
Exons
Genes
Antithrombins
Nonsense Codon
Venous Thrombosis
Nucleotides
Antithrombin Proteins
Sequence Deletion
Southern Blotting
Siblings
Leukocytes
Antigens
Amino Acids
DNA

Keywords

  • Antithrombin
  • Gene deletion
  • Nonsense mutation
  • Quasi palindrome
  • Venous thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Niiya, K., Kiguchi, T., Dansako, H., Fujimura, K., Fujimoto, T., Iijima, K., ... Harada, M. (2001). Two novel gene mutations in type I antithrombin deficiency. International Journal of Hematology, 74(4), 469-472.

Two novel gene mutations in type I antithrombin deficiency. / Niiya, Kenji; Kiguchi, Toru; Dansako, Hiromichi; Fujimura, Kingo; Fujimoto, Takahiro; Iijima, Kenji; Tanimoto, Mitsune; Harada, Mine.

In: International Journal of Hematology, Vol. 74, No. 4, 2001, p. 469-472.

Research output: Contribution to journalArticle

Niiya, K, Kiguchi, T, Dansako, H, Fujimura, K, Fujimoto, T, Iijima, K, Tanimoto, M & Harada, M 2001, 'Two novel gene mutations in type I antithrombin deficiency', International Journal of Hematology, vol. 74, no. 4, pp. 469-472.
Niiya K, Kiguchi T, Dansako H, Fujimura K, Fujimoto T, Iijima K et al. Two novel gene mutations in type I antithrombin deficiency. International Journal of Hematology. 2001;74(4):469-472.
Niiya, Kenji ; Kiguchi, Toru ; Dansako, Hiromichi ; Fujimura, Kingo ; Fujimoto, Takahiro ; Iijima, Kenji ; Tanimoto, Mitsune ; Harada, Mine. / Two novel gene mutations in type I antithrombin deficiency. In: International Journal of Hematology. 2001 ; Vol. 74, No. 4. pp. 469-472.
@article{52ae9c6925a744068866d7fe7ae7f003,
title = "Two novel gene mutations in type I antithrombin deficiency",
abstract = "We studied the molecular basis of type I antithrombin (AT) deficiency in 2 Japanese families, in which affected persons had histories of recurrent venous thrombosis and low (about 50{\%} of normal) levels of AT protein according to measurements by both functional and antigen assays. Southern blotting of DNA isolated from peripheral leukocytes revealed no abnormalities in all the cases examined. Direct sequencing of the polymerase chain reaction (PCR) products from case 1 suggested a novel heterozygous nonsense mutation in exon 4 (GAG→TAG at nucleotide position 7627, leading to Glu306 stop). The sequencing of the subclones of the patient's exon 4 products confirmed the nonsense mutation. No other sequence abnormalities were detected in the rest of the PCR products. The same mutation was detected in this patient's brother, who had a history of recurrent venous thrombosis and a reduced level of AT activity. In case 2, the direct sequencing of PCR products suggested a novel heterozygous 9-bp deletion in exon 3a(-CACTTC at nucleotide position 5354-5362, leading to the deletion of 3 amino acids, His120, Phe121, and Phe122). The 9-bp deletion mutation in the region of a unique quasi palindrome was confirmed by sequencing several of the subclones of the patient's exon 3a from the PCR products. No other mutations were found by direct sequencing of the rest of the coding regions. The 2 mutations found in this study are novel. The use of PCR and the sequencing of the PCR product subclones has simplified and confirmed the detection and characterization of the various AT muta-tions.",
keywords = "Antithrombin, Gene deletion, Nonsense mutation, Quasi palindrome, Venous thrombosis",
author = "Kenji Niiya and Toru Kiguchi and Hiromichi Dansako and Kingo Fujimura and Takahiro Fujimoto and Kenji Iijima and Mitsune Tanimoto and Mine Harada",
year = "2001",
language = "English",
volume = "74",
pages = "469--472",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Two novel gene mutations in type I antithrombin deficiency

AU - Niiya, Kenji

AU - Kiguchi, Toru

AU - Dansako, Hiromichi

AU - Fujimura, Kingo

AU - Fujimoto, Takahiro

AU - Iijima, Kenji

AU - Tanimoto, Mitsune

AU - Harada, Mine

PY - 2001

Y1 - 2001

N2 - We studied the molecular basis of type I antithrombin (AT) deficiency in 2 Japanese families, in which affected persons had histories of recurrent venous thrombosis and low (about 50% of normal) levels of AT protein according to measurements by both functional and antigen assays. Southern blotting of DNA isolated from peripheral leukocytes revealed no abnormalities in all the cases examined. Direct sequencing of the polymerase chain reaction (PCR) products from case 1 suggested a novel heterozygous nonsense mutation in exon 4 (GAG→TAG at nucleotide position 7627, leading to Glu306 stop). The sequencing of the subclones of the patient's exon 4 products confirmed the nonsense mutation. No other sequence abnormalities were detected in the rest of the PCR products. The same mutation was detected in this patient's brother, who had a history of recurrent venous thrombosis and a reduced level of AT activity. In case 2, the direct sequencing of PCR products suggested a novel heterozygous 9-bp deletion in exon 3a(-CACTTC at nucleotide position 5354-5362, leading to the deletion of 3 amino acids, His120, Phe121, and Phe122). The 9-bp deletion mutation in the region of a unique quasi palindrome was confirmed by sequencing several of the subclones of the patient's exon 3a from the PCR products. No other mutations were found by direct sequencing of the rest of the coding regions. The 2 mutations found in this study are novel. The use of PCR and the sequencing of the PCR product subclones has simplified and confirmed the detection and characterization of the various AT muta-tions.

AB - We studied the molecular basis of type I antithrombin (AT) deficiency in 2 Japanese families, in which affected persons had histories of recurrent venous thrombosis and low (about 50% of normal) levels of AT protein according to measurements by both functional and antigen assays. Southern blotting of DNA isolated from peripheral leukocytes revealed no abnormalities in all the cases examined. Direct sequencing of the polymerase chain reaction (PCR) products from case 1 suggested a novel heterozygous nonsense mutation in exon 4 (GAG→TAG at nucleotide position 7627, leading to Glu306 stop). The sequencing of the subclones of the patient's exon 4 products confirmed the nonsense mutation. No other sequence abnormalities were detected in the rest of the PCR products. The same mutation was detected in this patient's brother, who had a history of recurrent venous thrombosis and a reduced level of AT activity. In case 2, the direct sequencing of PCR products suggested a novel heterozygous 9-bp deletion in exon 3a(-CACTTC at nucleotide position 5354-5362, leading to the deletion of 3 amino acids, His120, Phe121, and Phe122). The 9-bp deletion mutation in the region of a unique quasi palindrome was confirmed by sequencing several of the subclones of the patient's exon 3a from the PCR products. No other mutations were found by direct sequencing of the rest of the coding regions. The 2 mutations found in this study are novel. The use of PCR and the sequencing of the PCR product subclones has simplified and confirmed the detection and characterization of the various AT muta-tions.

KW - Antithrombin

KW - Gene deletion

KW - Nonsense mutation

KW - Quasi palindrome

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0035755515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035755515&partnerID=8YFLogxK

M3 - Article

C2 - 11794707

AN - SCOPUS:0035755515

VL - 74

SP - 469

EP - 472

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 4

ER -